Related Experiment Video

Updated: Jul 4, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Sudden onset of pseudotuberculosis in humans, France, 2004-05

Pascal Vincent1, Alexandre Leclercq, Liliane Martin

  • 1Institut National de la Santé et de la Recherche Médicale (INSERM), Lille, France.

Emerging Infectious Diseases
|July 5, 2008
PubMed

Insights

Yersinia pseudotuberculosis infections rose in France during winter 2004-05. This transient pathogen amplification may stem from increased prevalence in rodent reservoirs.

Area of Science:

  • Microbiology
  • Epidemiology
  • Infectious Diseases

Background:

  • Yersinia pseudotuberculosis is an endemic pathogen.
  • Increased incidence of Yersinia pseudotuberculosis infections was observed in France during the 2004-05 winter season.
  • No clear epidemiologic links were identified between patient cases or bacterial strains.

Purpose of the Study:

  • To investigate the cause of the increased Yersinia pseudotuberculosis infections.
  • To understand the dynamics of pathogen amplification in the environment.

Main Methods:

  • Observational epidemiological study.
  • Analysis of infection case data.
  • Environmental surveillance (implied).

Main Results:

  • A transient increase in Yersinia pseudotuberculosis cases occurred.
  • The amplification was not linked to specific patient or strain clusters.
  • A potential association with increased pathogen prevalence in rodent reservoirs was suggested.

Conclusions:

  • The observed increase in Yersinia pseudotuberculosis infections likely represents transient environmental amplification.
  • Rodent populations may play a role in the cyclical prevalence of this pathogen.

More Related Videos

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...